Camp4 Therapeutics Corp Contracts & Agreements
19 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (1)
- Human Resources (8)
- Intellectual Property (3)
- Real Estate (2)
- CAMP4 Therapeutics Corporation Policy for Recoupment of Incentive Compensation (Filed With SEC on October 7, 2024)
- CAMP4 Therapeutics Corporation Non-Employee Director Compensation Policy (Filed With SEC on October 7, 2024)
- CAMP4 Therapeutics Corporation Severance and Change in Control Plan (Filed With SEC on October 7, 2024)
- CAMP4 Therapeutics Corporation 2024 Employee Stock Purchase Plan (Filed With SEC on October 7, 2024)
- Amended and Restated Employment Agreement by and between CAMP4 Therapeutics Corporation and Josh Mandel-Brehm, dated October 3, 2024 (Filed With SEC on October 7, 2024)
- Form of Non-Qualified Stock Option Award Agreement under the 2024 Equity Incentive Plan (Filed With SEC on October 7, 2024)
- Form of Incentive Stock Option Award Agreement under the 2024 Equity Incentive Plan (Filed With SEC on October 7, 2024)
- Form of Non-Qualified Stock Option Award Agreement for Non-Employee Directors under the 2024 Equity Incentive Plan (Filed With SEC on October 7, 2024)
- CAMP4 Therapeutics Corporation 2024 Equity Incentive Plan (Filed With SEC on October 7, 2024)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on September 26, 2024)
- Form of Underwriting Agreement (Filed With SEC on September 26, 2024)
- Third Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated June 3, 2022 (Filed With SEC on September 20, 2024)
- Lease by and between CAMP4 Therapeutics Corporation and BCSP Pearl East Property LLC, dated January 3, 2023 (Filed With SEC on September 20, 2024)
- Amended Lease agreement by and between CAMP4 Therapeutics Corporation and ARE-MA Region 59, LLC, dated October 3, 2019 (Filed With SEC on September 20, 2024)
- CAMP4 Therapeutics Corporation Amended and Restated 2016 Stock Option and Grant Plan, as amended, and form of award agreements thereunder (Filed With SEC on September 20, 2024)
- Second Amendment to Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of November 7, 2023 (Filed With SEC on September 20, 2024)
- First Amendment to Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of December 14, 2021 (Filed With SEC on September 20, 2024)
- Patent License Agreement by and between CAMP4 Therapeutics Corporation and the Whitehead Institute for Biomedical Research, dated as of October 23, 2019 (Filed With SEC on September 20, 2024)
- Warrant to Purchase Stock, by and between Silicon Valley Bank and CAMP4 Therapeutics Corporation (f/k/a Marauder Therapeutics, Inc.), dated January 4, 2017 (Filed With SEC on September 20, 2024)
